Production of anti-spike antibodies in response to COVID vaccine in lymphoma patients

Data Availability
The study involves a review of the electronic medical records of lymphoma patients who received the COVID vaccine. The research data set has removed most, but not all protected health information (for example: actual dates of antibody testing were included as needed for analysis, but would be considered PHI). The dataset is also considered property of Hackensack Meridian Health and not owned by the investigators. Therefore, for both reasons, the dataset cannot be made openly available. However, upon request we are willing to share portions of the data for appropriate review. Requests can be made through the corresponding author or directly to representatives of Hackensack Meridian Health (Dr Andrew Ip Email: Andrew.Ip{at}hmhn.org).
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
- Addiction Medicine (419)
- Allergy and Immunology (741)
- Anesthesia (217)
- Cardiovascular Medicine (3193)
- Dermatology (270)
- Emergency Medicine (473)
- Epidemiology (13180)
- Forensic Medicine (19)
- Gastroenterology (883)
- Genetic and Genomic Medicine (5011)
- Geriatric Medicine (467)
- Health Economics (767)
- Health Informatics (3154)
- Health Policy (1119)
- Hematology (418)
- HIV/AIDS (992)
- Medical Education (466)
- Medical Ethics (123)
- Nephrology (512)
- Neurology (4764)
- Nursing (253)
- Nutrition (706)
- Oncology (2452)
- Ophthalmology (696)
- Orthopedics (274)
- Otolaryngology (335)
- Pain Medicine (317)
- Palliative Medicine (89)
- Pathology (525)
- Pediatrics (1270)
- Primary Care Research (542)
- Public and Global Health (7325)
- Radiology and Imaging (1648)
- Respiratory Medicine (959)
- Rheumatology (469)
- Sports Medicine (413)
- Surgery (531)
- Toxicology (68)
- Transplantation (227)
- Urology (197)